Aytu Accounts Payable from 2010 to 2025

AYTU Stock  USD 1.24  0.01  0.80%   
Aytu BioScience Accounts Payable yearly trend continues to be comparatively stable with very little volatility. Accounts Payable is likely to outpace its year average in 2025. Accounts Payable is the amount Aytu BioScience owes to suppliers or vendors for products or services received but not yet paid for. It represents Aytu BioScience's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2007-06-30
Previous Quarter
13.5 M
Current Value
11.7 M
Quarterly Volatility
6.1 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Aytu BioScience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aytu BioScience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 10 M, Interest Expense of 5.2 M or Selling General Administrative of 27.2 M, as well as many indicators such as Price To Sales Ratio of 289, Dividend Yield of 0.0 or PTB Ratio of 3.5. Aytu financial statements analysis is a perfect complement when working with Aytu BioScience Valuation or Volatility modules.
  
Check out the analysis of Aytu BioScience Correlation against competitors.
For more information on how to buy Aytu Stock please use our How to Invest in Aytu BioScience guide.

Latest Aytu BioScience's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Aytu BioScience over the last few years. An accounting item on the balance sheet that represents Aytu BioScience obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Aytu BioScience are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Aytu BioScience's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aytu BioScience's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Aytu Accounts Payable Regression Statistics

Arithmetic Mean6,413,416
Geometric Mean1,341,252
Coefficient Of Variation98.27
Mean Deviation5,712,868
Median3,519,711
Standard Deviation6,302,566
Sample Variance39.7T
Range19.3M
R-Value0.83
Mean Square Error12.9T
R-Squared0.70
Significance0.000057
Slope1,105,132
Total Sum of Squares595.8T

Aytu Accounts Payable History

202512.6 M
202412 M
202310.4 M
202213.5 M
202111 M
202019.3 M
201911.8 M

About Aytu BioScience Financial Statements

Aytu BioScience shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although Aytu BioScience investors may analyze each financial statement separately, they are all interrelated. The changes in Aytu BioScience's assets and liabilities, for example, are also reflected in the revenues and expenses on on Aytu BioScience's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Accounts Payable12 M12.6 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Aytu Stock Analysis

When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.